- 3,753
- 4,198
Regarding the prospects for adaptive immunity from COVID-19:
In studies with monkeys, infection with COVID-19 provides immunity to the disease in the short term, suggesting that re-infection is unlikely or rare and that a vaccine should be able to produce immunity. A bigger concern may be that our body's immune response to the virus can wane over time. Our experience with the four other endemic coronaviruses suggests that infection provides short term immunity that wanes over time, and studies on people who were infected by the similar SARS virus from the 2003 outbreak also suggests that levels of antibodies against the virus wane over the course of a few years. A non-peer-reviewed pre-print looking for the presence of antibodies in the blood of those with confirmed COVID-19 infections found that up to ~1/3 had low or no detectable antibodies (mostly from people who had mild cases), which could be a concern for the possibility of re-infection. However, as @atyy mentioned, it is not clear whether these antibody tests truly reflect immunity, and it is possible that some of the people with low/no detectable antibodies still have immunity, but the particular test is not able to detect the antibodies.
Current evidence suggests that the mutation rate of the virus is slow enough that we should not expect that the virus will mutate to avoid immunity. Of course, mutations can be unpredictable, so mutation to avoid immunity is always a possibility, though something that can be monitored.
Here's a good summary of what we know regarding immunity to COVID-19 from STAT news: https://www.statnews.com/2020/04/20...nity-and-antibodies-and-plenty-we-still-dont/
In studies with monkeys, infection with COVID-19 provides immunity to the disease in the short term, suggesting that re-infection is unlikely or rare and that a vaccine should be able to produce immunity. A bigger concern may be that our body's immune response to the virus can wane over time. Our experience with the four other endemic coronaviruses suggests that infection provides short term immunity that wanes over time, and studies on people who were infected by the similar SARS virus from the 2003 outbreak also suggests that levels of antibodies against the virus wane over the course of a few years. A non-peer-reviewed pre-print looking for the presence of antibodies in the blood of those with confirmed COVID-19 infections found that up to ~1/3 had low or no detectable antibodies (mostly from people who had mild cases), which could be a concern for the possibility of re-infection. However, as @atyy mentioned, it is not clear whether these antibody tests truly reflect immunity, and it is possible that some of the people with low/no detectable antibodies still have immunity, but the particular test is not able to detect the antibodies.
Current evidence suggests that the mutation rate of the virus is slow enough that we should not expect that the virus will mutate to avoid immunity. Of course, mutations can be unpredictable, so mutation to avoid immunity is always a possibility, though something that can be monitored.
Here's a good summary of what we know regarding immunity to COVID-19 from STAT news: https://www.statnews.com/2020/04/20...nity-and-antibodies-and-plenty-we-still-dont/